HEALTHCARE PROFESIONALS WERE TRAINED IN ADVERSE DRUG REACTION REPORTING AND RATIONAL USE OF MEDICINES AND MEDICAL DEVICES

On 10 October 2018 the Conference “Raising Awareness of the Adverse Drug Reaction Reporting and Rational Use of Medicines and Medical Devices - Challenges and Best Practice” has been successfully concluded within the the EU-funded Twinning Project “Strengthening of the Medicines and Medical Devices Agency of the Republic of Moldova as regulatory agency in the field of medicines, medical devices and pharmaceutical activity”. 

The conference was attended by the Minister of Health, Labour and Social Protection of the Republic of Moldova, Ms. Silvia Radu, the General State Chancellor of the Health, Labour and Social Protection of the Republic of Moldova, Mr. Boris Gilca, the Director of the State Medicines Control Agency of the Ministry of Health of the Republic of Lithuania, Mr. Gintautas Barcys, the General Director of the MMDA, Mr. Vladislav Zara, the Vice-President for Medicinal Products of the Office of Medicines, Medical Devices and Biocides of the Republic of Poland, Mr. Marcin Kolakowski, the EU High Level Adviser on Health Reform, Prof. Juozas Galdikas, the Resident Twinning Adviser Ms. Anželika Oraitė and the Resident Twinning Counterpart Ms. Corina Iacob.

The main purpose of the Conference was to raise the awareness of adverse drug reaction (ADR) reporting and rational use of medicines and medical devices as well as to share the best EU practice.

Experts from the Ministry of Health of the Republic of Lithuania, the State Medicines Control Agency under the Ministry of Health of the Republic of Lithuania and the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of the Republic of Poland shared their best practices on European pharmacovigilance system, safety monitoring and impact on safety of medicinal products, educational materials and safety communication in European practice, campaigns in health care, as well as rational use of medicines and medical devices.

Additionally, during the conference, the latest measures taken to strengthen the pharmacovigilance system in the Republic of Moldova, effective collection and systematization of information on adverse drug reactions were presented by the Moldavian experts. Representatives from the Institute of Pulmonology and Phthisiology „Chiril Draganiuc” shared their experience in adverse drug reactions reporting.

In total, more than one hundred participants attended the event. 

The main purpose this EU-funded project worth 1 100 000 EUR is to strengthen the functioning of the MMDA with regards to medicinal products manufacturing, marketing, pharmacovigilance, distribution and pricing and medical devices in scope of market supervision, vigilance and registration as well as to clinical trials and pharmaceutical activity. The completion of this EU-funded Project should deliver the MMDA with capacities at the same level as peer institutions in the EU Member States and should allow patients to benefit from safer, better quality and more effective medicinal products and medical devices.

 

Noutăţi

11
oct
2016

Atribuțiile AMDM de coordonare a procesului de aprovizionare cu medicamente a spitalelor vor fi preluate de Centrul pentru achiziții publice centralizate în sănătate.

08
aug
2016

   Curs de instruire cu tema ”GРP. Reguli de bună practică de farmacie”

04
aug
2016

        Lipsa unor produse farmaceutice din țară, discutată de AMDM și distribuitorii de medicamente

Development and support SEMSEO

(c) 2015. Medicines Agency and medical devices